Brain-computer interface training improves global cognitive function in stroke survivors with SMD=0.62
Brain computer interface training improves cognitive function after stroke
This systematic review and meta-analysis of randomized controlled trials indicates that brain-computer interface (BCI) training significantl…
New data shows that brain-computer interface training can improve focus and daily tasks for people recovering from a stroke.
Exercise, microbiota, and tRNA modifications may influence mitochondrial function and proteostasis in Parkinson's disease
Exercise and gut health may protect brain cells in Parkinson's
This narrative review explores the exercise-microbiota-queuine-tRNA axis as a potential mechanism for dopaminergic neuroprotection in Parkin…
New research explores how exercise, gut bacteria, and RNA modifications might work together to protect the brain from Parkinson's disease.
Repetitive transcranial magnetic stimulation may enhance upper limb motor function following a stroke
Magnetic stimulation may help arm movement after a stroke
This overview of systematic reviews analyzed 17 meta-analyses and systematic reviews regarding repetitive transcranial magnetic stimulation …
A review of several studies suggests that magnetic brain stimulation could improve arm movement for people recovering from a stroke.
Transcarotid Artery Revascularization shows lower 30-day stroke and death risk compared to TF-CAS
New data shows TCAR may lower risks for carotid artery disease
This meta-analysis of patients with carotid stenosis found that Transcarotid Artery Revascularization (TCAR) showed no significant differenc…
A new analysis finds that the TCAR procedure may offer better safety outcomes than stenting for patients with asymptomatic carotid artery bl…
Menopause does not appear to be a distinct clinical inflection point for multiple sclerosis progression
Menopause does not appear to be a turning point for MS
This narrative review examines the impact of menopause and biological aging on women with multiple sclerosis. The authors conclude that whil…
While menopause can make symptoms harder to manage, it is not a clear biological turning point for the progression of multiple sclerosis.
Advanced experimental models and computational tools provide dynamic frameworks for understanding oral disease progression
New Research Tools Help Map Complex Oral Diseases
This mini-review examines the integration of advanced experimental models, such as organ-on-chip systems and patient-derived organoids, with…
Advanced modeling and AI tools are helping researchers better understand the molecular causes behind conditions like gum disease and oral ca…
Traumatic BPPV triples recurrence risk versus idiopathic BPPV in meta-analysis of 4,074 patients
Traumatic vertigo cases show higher rates of recurring symptoms
A meta-analysis of 4,074 patients found that traumatic BPPV (t-BPPV) has significantly poorer outcomes than idiopathic BPPV (i-BPPV), with a…
People with vertigo caused by an injury may face a much higher risk of their symptoms returning compared to those with the condition on its …
FDA Approves Ajovy (fremanezumab) for Preventive Migraine Treatment in Adults and Pediatric Patients
FDA approves Ajovy to prevent migraines in adults and children.
The FDA approved Ajovy (fremanezumab) for preventive treatment of migraine in adults and episodic migraine in pediatric patients aged 6-17 y…
The FDA approved Ajovy (fremanezumab) to prevent migraines in adults and in children ages 6 to 17 who weigh at least 45 kg. It is a monthly …
FDA Approves Emgality (galcanezumab) for Preventive Treatment of Migraine and Episodic Cluster Headache
FDA approves new monthly shot Emgality to prevent migraines and treat cluster headaches.
The FDA approved Emgality (galcanezumab) for preventive treatment of migraine and treatment of episodic cluster headache in adults. In two 6…
The FDA approved Emgality (galcanezumab) to prevent migraines and treat episodic cluster headaches in adults. It is a monthly injection that…
FDA Approves Vyepti (eptinezumab-jjmr) for Preventive Treatment of Migraine in Adults
FDA approves new migraine prevention drug Vyepti given by IV every 3 months
FDA approved Vyepti (eptinezumab-jjmr) for preventive treatment of migraine in adults. It is a calcitonin gene-related peptide antagonist ad…
The FDA approved Vyepti (eptinezumab-jjmr) to prevent migraines in adults. It is given as an IV infusion every three months. This offers a n…
FDA Approves Epidiolex (cannabidiol) for Seizures Associated with LGS, DS, or TSC
FDA approves new cannabis-based drug for severe epilepsy in children.
FDA approved Epidiolex (cannabidiol) oral solution for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclero…
The FDA approved Epidiolex, a purified cannabis-derived drug, for seizures in patients aged 1 year and older with Lennox-Gastaut syndrome, D…
MIND diet shows greater cognitive improvement in community-dwelling adults with high biomarker levels over three years
MIND diet linked to better brain health in older adults with high biomarkers
In a randomized clinical trial, the MIND diet demonstrated superior longitudinal cognitive outcomes compared to a control diet among older a…
Older adults on the MIND diet showed greater cognitive improvement than controls when they had higher levels of specific brain biomarkers.